{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:08:22Z","timestamp":1767625702245},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T00:00:00Z","timestamp":1250726400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Catheter-related bacteraemias (CRBs) contribute significantly to morbidity, mortality and health care costs in dialysis populations. Despite international guidelines recommending avoidance of catheters for haemodialysis access, hospital admissions for CRBs have doubled in the last decade. The primary aim of the study is to determine whether weekly instillation of 70% ethanol prevents CRBs compared with standard heparin saline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/design<\/jats:title>\n            <jats:p>The study will follow a prospective, open-label, randomized controlled design. Inclusion criteria are adult patients with incident or prevalent tunneled intravenous dialysis catheters on three times weekly haemodialysis, with no current evidence of catheter infection and no personal, cultural or religious objection to ethanol use, who are on adequate contraception and are able to give informed consent. Patients will be randomized 1:1 to receive 3 mL of intravenous-grade 70% ethanol into each lumen of the catheter once a week and standard heparin locks for other dialysis days, or to receive heparin locks only. The primary outcome measure will be time to the first episode of CRB, which will be defined using standard objective criteria. Secondary outcomes will include adverse reactions, incidence of CRB caused by different pathogens, time to infection-related catheter removal, time to exit site infections and costs. Prospective power calculations indicate that the study will have 80% statistical power to detect a clinically significant increase in median infection-free survival from 200 days to 400 days if 56 patients are recruited into each arm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This investigator-initiated study has been designed to provide evidence to help nephrologists reduce the incidence of CRBs in haemodialysis patients with tunnelled intravenous catheters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial Registration<\/jats:title>\n            <jats:p>Australian New Zealand Clinical Trials Registry Number: ACTRN12609000493246<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-10-23","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T06:13:31Z","timestamp":1250748811000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients"],"prefix":"10.1186","volume":"10","author":[{"given":"Jennifer K","family":"Broom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridevi","family":"Govindarajulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Geoffrey","family":"Playford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmel M","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Mudge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara C","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil P","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,20]]},"reference":[{"key":"132_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7326\/0003-4819-127-4-199708150-00003","volume":"127","author":"KA Marr","year":"1997","unstructured":"Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997, 127: 275-280.","journal-title":"Ann Intern Med"},{"key":"132_CR2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1681\/ASN.V961085","volume":"9","author":"R Sesso","year":"1998","unstructured":"Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al: Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol. 1998, 9: 1085-1092.","journal-title":"J Am Soc Nephrol"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/17.10.1802","volume":"17","author":"DW Johnson","year":"2002","unstructured":"Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al: A randomized, controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002, 17: 1802-1807. 10.1093\/ndt\/17.10.1802.","journal-title":"Nephrol Dial Transplant"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1681\/ASN.2004110997","volume":"16","author":"DW Johnson","year":"2005","unstructured":"Johnson DW, van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, et al: Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol. 2005, 16: 1456-1462. 10.1681\/ASN.2004110997.","journal-title":"J Am Soc Nephrol"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.ASN.0000109668.05157.05","volume":"15","author":"KR Polkinghorne","year":"2004","unstructured":"Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004, 15: 477-486. 10.1097\/01.ASN.0000109668.05157.05.","journal-title":"J Am Soc Nephrol"},{"key":"132_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)70056-0","volume":"41","author":"USRDS","year":"2003","unstructured":"USRDS: Excerpts from the USRDS 2002 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003, 41: S1-S260.","journal-title":"Am J Kidney Dis"},{"key":"132_CR7","first-page":"13","volume-title":"Contrib Nephrol","author":"RL Pisoni","year":"2002","unstructured":"Pisoni RL: Vascular access use and outcomes: results from the DOPPS. Contrib Nephrol. 2002, 13-19. full_text."},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1046\/j.1523-1755.2003.00277.x","volume":"64","author":"KR Polkinghorne","year":"2003","unstructured":"Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int. 2003, 64: 1893-1902. 10.1046\/j.1523-1755.2003.00277.x.","journal-title":"Kidney Int"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1053\/j.ajkd.2003.11.023","volume":"43","author":"KR Polkinghorne","year":"2004","unstructured":"Polkinghorne KR, McDonald SP, Marshall MR, Atkins RC, Kerr PG: Vascular access practice patterns in the New Zealand hemodialysis population. Am J Kidney Dis. 2004, 43: 696-704. 10.1053\/j.ajkd.2003.11.023.","journal-title":"Am J Kidney Dis"},{"key":"132_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/112972980700800105","volume":"8","author":"A Di Benedetto","year":"2007","unstructured":"Di Benedetto A, Basci A, Cesare S, Marcelli D, Ponce P, Richards N: Increased use of catheters as vascular access: is it justified by patients' clinical conditions?. J Vasc Access. 2007, 8: 21-27.","journal-title":"J Vasc Access"},{"key":"132_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/ndt\/gfi281","volume":"21","author":"DC Mendelssohn","year":"2006","unstructured":"Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL: Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant. 2006, 21: 721-728. 10.1093\/ndt\/gfi281.","journal-title":"Nephrol Dial Transplant"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1523-1755.2002.00117.x","volume":"61","author":"RL Pisoni","year":"2002","unstructured":"Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, et al: Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002, 61: 305-316. 10.1046\/j.1523-1755.2002.00117.x.","journal-title":"Kidney Int"},{"key":"132_CR13","first-page":"13","volume-title":"Contrib Nephrol","author":"RL Pisoni","year":"2002","unstructured":"Pisoni RL: Vascular access use and outcomes: results from the DOPPS. Contrib Nephrol. 2002, 13-19. full_text."},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1523-1755.1999.00512.x","volume":"56","author":"SJ Schwab","year":"1999","unstructured":"Schwab SJ, Beathard G: The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int. 1999, 56: 1-17. 10.1046\/j.1523-1755.1999.00512.x.","journal-title":"Kidney Int"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ndt\/gfh729","volume":"20","author":"M Allon","year":"2005","unstructured":"Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, et al: The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant. 2005, 20: 1180-1186. 10.1093\/ndt\/gfh729.","journal-title":"Nephrol Dial Transplant"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1523-1755.2005.00414.x","volume":"68","author":"A Ishani","year":"2005","unstructured":"Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int. 2005, 68: 311-318. 10.1111\/j.1523-1755.2005.00414.x.","journal-title":"Kidney Int"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1046\/j.1523-1755.2001.00947.x","volume":"60","author":"RK Dhingra","year":"2001","unstructured":"Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001, 60: 1443-1451. 10.1046\/j.1523-1755.2001.00947.x.","journal-title":"Kidney Int"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1523-1755.2002.00460.x","volume":"62","author":"S Pastan","year":"2002","unstructured":"Pastan S, Soucie JM, McClellan WM: Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002, 62: 620-626. 10.1046\/j.1523-1755.2002.00460.x.","journal-title":"Kidney Int"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.ASN.0000109668.05157.05","volume":"15","author":"KR Polkinghorne","year":"2004","unstructured":"Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004, 15: 477-486. 10.1097\/01.ASN.0000109668.05157.05.","journal-title":"J Am Soc Nephrol"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/infdis\/154.4.579","volume":"154","author":"JS Cheesbrough","year":"1986","unstructured":"Cheesbrough JS, Finch RG, Burden RP: A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis. 1986, 154: 579-589.","journal-title":"J Infect Dis"},{"key":"132_CR21","first-page":"1","volume":"51","author":"NP O'Grady","year":"2002","unstructured":"O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al: Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002, 51: 1-29.","journal-title":"MMWR Recomm Rep"},{"key":"132_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/089686080502500203","volume":"25","author":"B Piraino","year":"2005","unstructured":"Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005, 25: 107-131.","journal-title":"Perit Dial Int"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1053\/j.ajkd.2008.09.019","volume":"53","author":"SA Abbas","year":"2009","unstructured":"Abbas SA, Haloob IA, Taylor SL, Curry EM, King BB, Merwe Van der WM, et al: Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am J Kidney Dis. 2009, 53: 492-502. 10.1053\/j.ajkd.2008.09.019.","journal-title":"Am J Kidney Dis"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1097\/01.ASN.0000022890.29656.22","volume":"13","author":"GK Dogra","year":"2002","unstructured":"Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al: Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol. 2002, 13: 2133-2139. 10.1097\/01.ASN.0000022890.29656.22.","journal-title":"J Am Soc Nephrol"},{"key":"132_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1086\/588667","volume":"47","author":"D Yahav","year":"2008","unstructured":"Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M: Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008, 47: 83-93. 10.1086\/588667.","journal-title":"Clin Infect Dis"},{"key":"132_CR26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.01.259","volume":"53","author":"A Power","year":"2009","unstructured":"Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, et al: Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis. 2009, 53: 1034-1041. 10.1053\/j.ajkd.2009.01.259.","journal-title":"Am J Kidney Dis"},{"key":"132_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jhin.2006.01.009","volume":"63","author":"ST Chambers","year":"2006","unstructured":"Chambers ST, Peddie B, Pithie A: Ethanol disinfection of plastic-adherent micro-organisms. J Hosp Infect. 2006, 63: 193-196. 10.1016\/j.jhin.2006.01.009.","journal-title":"J Hosp Infect"},{"key":"132_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/rcm.2837","volume":"21","author":"S Guenu","year":"2007","unstructured":"Guenu S, Heng AE, Charbonne F, Galmier MJ, Charles F, Deteix P, et al: Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60% ethanol solution. Rapid Commun Mass Spectrom. 2007, 21: 229-236. 10.1002\/rcm.2837.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"132_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/502607","volume":"26","author":"CJ Crnich","year":"2005","unstructured":"Crnich CJ, Halfmann JA, Crone WC, Maki DG: The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005, 26: 708-714. 10.1086\/502607.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"132_CR30","first-page":"S8","volume":"23","author":"Bureau of Infectious Diseases Division of Nosocomial and Occupational Infections","year":"1997","unstructured":"Bureau of Infectious Diseases Division of Nosocomial and Occupational Infections: Infection control guidelines: Preventing infections associated with indwelling intravascular access devices. Health Canada. 1997, 23: S8-S11.","journal-title":"Health Canada"},{"key":"132_CR31","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1097\/00003246-199808000-00038","volume":"26","author":"AG Randolph","year":"1998","unstructured":"Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C: Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med. 1998, 26: 1452-1457. 10.1097\/00003246-199808000-00038.","journal-title":"Crit Care Med"},{"key":"132_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJM197706092962301","volume":"296","author":"DG Maki","year":"1977","unstructured":"Maki DG, Weise CE, Sarafin HW: A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977, 296: 1305-1309.","journal-title":"N Engl J Med"},{"key":"132_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2003.08.010","volume":"49","author":"SC Metcalf","year":"2004","unstructured":"Metcalf SC, Chambers ST, Pithie AD: Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004, 49: 20-22. 10.1016\/j.jinf.2003.08.010.","journal-title":"J Infect"},{"key":"132_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00365540701756953","volume":"40","author":"J Broom","year":"2008","unstructured":"Broom J, Woods M, Allworth A, McCarthy J, Faoagali J, Macdonald S, et al: Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis. 2008, 40: 399-406. 10.1080\/00365540701756953.","journal-title":"Scand J Infect Dis"},{"key":"132_CR35","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/ndt\/gfl358","volume":"21","author":"C Ackoundou-N'guessan","year":"2006","unstructured":"Ackoundou-N'guessan C, Heng AE, Guenu S, Charbonne F, Traore O, Deteix P, et al: Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis \u2013 first case report in dialysis setting. Nephrol Dial Transplant. 2006, 21: 3339-3340. 10.1093\/ndt\/gfl358.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-10-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:22:02Z","timestamp":1630448522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-10-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-10-23","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,20]]},"assertion":[{"value":"13 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}